Performance of ImproGene Cell-Free DNA Tubes for Stabilization and Analysis of cfDNA in Blood Samples

References

• Jahr S, Hentze H, Englisch S, Hardt D, Fackelmayer FO, Hesch RD, Knippers R. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res. 2001;61(4):1659–65.
   PubMed Web of Science ®Google Scholar
• Lo YMD, Chan KCA, Sun H, Chen EZ, Jiang P, Lun FMF, Zheng YW, Leung TY, Lau TK, Cantor CR, et al. Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci Transl Med. 2010;2(61):61ra91. doi:10.1126/scitranslmed.3001720.
   PubMed Web of Science ®Google Scholar
• Stroun M, Anker P, Maurice P, Lyautey J, Lederrey C, Beljanski M. Neoplastic characteristics of the DNA found in the plasma of cancer patients. Oncology. 1989;46(5):318–22. doi:10.1159/000226740.
   PubMed Web of Science ®Google Scholar
• Lo YMD, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, Wainscoat JS. Presence of fetal DNA in maternal plasma and serum. The Lancet. 1997;350(9076):485–7. doi:10.1016/S0140-6736(97)02174-0.
   PubMed Web of Science ®Google Scholar
• Duvvuri B, Lood C. Cell-free DNA as a biomarker in autoimmune rheumatic diseases. Front Immunol. 2019;10:502. doi:10.3389/fimmu.2019.00502.
   PubMed Web of Science ®Google Scholar
• Salvi S, Gurioli G, De Giorgi U, Conteduca V, Tedaldi G, Calistri D, Casadio V. Cell-free DNA as a diagnostic marker for cancer: current insights. Onco Targets Ther. 2016;9:6549–59. doi:10.2147/OTT.S100901.
   PubMed Web of Science ®Google Scholar
• Hampson P, Dinsdale RJ, Wearn CM, Bamford AL, Bishop JRB, Hazeldine J, Moiemen NS, Harrison P, Lord JM. Neutrophil dysfunction, immature granulocytes, and cell-free DNA are early biomarkers of sepsis in burn-injured patients: a prospective observational cohort study. Ann Surg. 2017;265(6):1241–9. doi:10.1097/SLA.0000000000001807.
   PubMed Web of Science ®Google Scholar
• Zhang J, Li J, Saucier JB, Feng Y, Jiang Y, Sinson J, McCombs AK, Schmitt ES, Peacock S, Chen S, et al. Non-invasive prenatal sequencing for multiple Mendelian monogenic disorders using circulating cell-free fetal DNA. Nat Med. 2019;25(3):439–47. doi:10.1038/s41591-018-0334-x.
   PubMed Web of Science ®Google Scholar
• Peng XL, Jiang P. Bioinformatics approaches for fetal DNA fraction estimation in noninvasive prenatal testing. Int J Mol Sci. 2017;18(2):453.
   PubMed Web of Science ®Google Scholar
• Luo Y, Jia B, Yan K, Liu S, Song X, Chen M, Jin F, Du Y, Wang J, Hong Y, et al. Pilot study of a novel multi-functional noninvasive prenatal test on fetus aneuploidy, copy number variation, and single-gene disorder screening. Mol Genet Genomic Med. 2019;7(4):e00597. doi:10.1002/mgg3.597.
   PubMed Web of Science ®Google Scholar
• Song Y, Zhou X, Huang S, Li X, Qi Q, Jiang Y, Liu Y, Ma C, Li Z, Xu M, et al. Quantitation of fetal DNA fraction in maternal plasma using circulating single molecule amplification and re-sequencing technology (cSMART). Clin Chim Acta. 2016;456:151–6. doi:10.1016/j.cca.2016.03.005.
   PubMed Web of Science ®Google Scholar
• Gil MM, Accurti V, Santacruz B, Plana MN, Nicolaides KH. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol. 2017;50(3):302–14. doi:10.1002/uog.17484.
   PubMed Web of Science ®Google Scholar
• Gregg AR, Skotko BG, Benkendorf JL, Monaghan KG, Bajaj K, Best RG, Klugman S, Watson MS. Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics. Genet Med. 2016;18(10):1056–65. doi:10.1038/gim.2016.97.
   PubMed Web of Science ®Google Scholar
• Dahl F, Ericsson O, Karlberg O, Karlsson F, Howell M, Persson F, Roos F, Stenberg J, Ahola T, Alftrén I, et al. Imaging single DNA molecules for high precision NIPT. Sci Rep. 2018;8(1):4549. doi:10.1038/s41598-018-22606-0.
   PubMed Web of Science ®Google Scholar
• Hu P, Liang D, Chen Y, Lin Y, Qiao F, Li H, Wang T, Peng C, Luo D, Liu H, et al. An enrichment method to increase cell-free fetal DNA fraction and significantly reduce false negatives and test failures for non-invasive prenatal screening: a feasibility study. J Transl Med. 2019;17(1):124. doi:10.1186/s12967-019-1871-x.
   PubMedGoogle Scholar
• Sorber L, Zwaenepoel K, Jacobs J, De Winne K, Van Casteren K, Augustus E, Lardon F, Prenen H, Peeters M, Van Meerbeeck J, et al. Specialized blood collection tubes for liquid biopsy: improving the pre-analytical conditions. Mol Diagn Ther. 2020;24(1):113–24. doi:10.1007/s40291-019-00442-w.
   PubMed Web of Science ®Google Scholar
• Medina Diaz I, Nocon A, Mehnert DH, Fredebohm J, Diehl F, Holtrup F. Performance of streck cfDNA blood collection tubes for liquid biopsy testing. PLoS One. 2016;11(11):e0166354. doi:10.1371/journal.pone.0166354.
   PubMed Web of Science ®Google Scholar
• Toro PV, Erlanger B, Beaver JA, Cochran RL, VanDenBerg DA, Yakim E, Cravero K, Chu D, Zabransky DJ, Wong HY, et al. Comparison of cell stabilizing blood collection tubes for circulating plasma tumor DNA. Clin Biochem. 2015;48(15):993–8. doi:10.1016/j.clinbiochem.2015.07.097.
   PubMed Web of Science ®Google Scholar
• Enko D, Halwachs-Baumann G, Kriegshäuser G. Plasma free DNA: evaluation of temperature-associated storage effects observed for Roche Cell-Free DNA collection tubes. Biochem Med (Zagreb). 2019;29(1):010904. doi:10.11613/BM.2019.010904.
   PubMed Web of Science ®Google Scholar
• Norton SE, Lechner JM, Williams T, Fernando MR. A stabilizing reagent prevents cell-free DNA contamination by cellular DNA in plasma during blood sample storage and shipping as determined by digital PCR. Clin Biochem. 2013;46(15):1561–5. doi:10.1016/j.clinbiochem.2013.06.002.
   PubMed Web of Science ®Google Scholar
• Nishimura F, Uno N, Chiang P-C, Kaku N, Morinaga Y, Hasegawa H, Yanagihara K. The effect of in vitro hemolysis on measurement of cell-free DNA. J Appl Lab Med. 2019;4(2):235–40. doi:10.1373/jalm.2018.027953.
   PubMedGoogle Scholar
• Langlois S, Brock J-A, Douglas Wilson R, GENETICS COMMITTEE. Current status in non-invasive prenatal detection of down syndrome, trisomy 18, and trisomy 13 using cell-free DNA in maternal plasma. J Obstet Gynaecol Can. 2013;35(2):177–81. doi:10.1016/S1701-2163(15)31025-2.
   PubMedGoogle Scholar
• Stokowski R, White K, Hacker C, Doshi J, Schmid M. Hemolysis and fetal fraction in cell-free DNA blood collection tubes for noninvasive prenatal testing. Mol Diagn Ther. 2020;24(2):185–90. doi:10.1007/s40291-020-00446-x.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Li Y, Chen P, Li S, Luo J, Xia H. Performance comparison of blood collection tubes as liquid biopsy storage system for minimizing cfDNA contamination from genomic DNA. J Clin Lab Anal. 2019;33(2):e22670. doi:10.1002/jcla.22670.
   PubMed Web of Science ®Google Scholar
• Li W. On parameters of the human genome. J Theor Biol. 2011;288:92–104. doi:10.1016/j.jtbi.2011.07.021.
   PubMed Web of Science ®Google Scholar
• Chen Y-P, He Z-Q, Shi Y, Zhou Q, Cai Z-M, Yu B, Wang T. Not all chromosome aberrations can be detected by NIPT in women at advanced maternal age: a multicenter retrospective study. Clin Chim Acta. 2018;486:232–6. doi:10.1016/j.cca.2018.08.018.
   PubMed Web of Science ®Google Scholar